Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
8.84
-0.04 (-0.45%)
Oct 28, 2026, 2:05 PM CST

SHE:002332 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
465.17449.64397.18563.08749.41619.33
Depreciation & Amortization
216.95218.95226.74218.91193189.52
Other Amortization
8.46.41.932.272.744.32
Loss (Gain) From Sale of Assets
-46.3-46.3-0.281.48-91.62-14.51
Asset Writedown & Restructuring Costs
30.971.821.310.420.911.68
Loss (Gain) From Sale of Investments
26.4126.418.087.17-49.35-29.22
Provision & Write-off of Bad Debts
-0.245.4410.95-7.294-
Other Operating Activities
498.3650.3239.3142.5332.3825.45
Change in Accounts Receivable
-275.98-275.98-280.88-203.22-129.7769.04
Change in Inventory
-6.4-6.4-88.14-105.98-92.65-233.44
Change in Accounts Payable
-178.12-178.1289.669.36-9.7924.19
Operating Cash Flow
734.52247.48398.66595.48609.28657.9
Operating Cash Flow Growth
137.91%-37.92%-33.05%-2.27%-7.39%-16.64%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-159.9-209.07-207.59-234.63-282.54-248.58
Sale of Property, Plant & Equipment
5.310.7647.261.314.0337.74
Divestitures
10.4610.46-48.2269.88-
Investment in Securities
-3.71.71-24.3-16.33507.046.53
Other Investing Activities
1.65-4.214.8159.67-0.38
Investing Cash Flow
-146.18-196.14-180.42-196.63358.07-204.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
--3.45---
Long-Term Debt Issued
-414.955.621.36198.15433.79
Total Debt Issued
375.45414.959.071.36198.15433.79
Long-Term Debt Repaid
--276-174.03-158.86-584.73-808.94
Lease Payments
-5.05-5.05-4.5-10.39-6.08-5.54
Net Debt Issued (Repaid)
-15.88138.95-164.97-157.5-386.58-375.16
Common Dividends Paid
-440.91-401.51-298.19-299.77-154.22-172.13
Other Financing Activities
-154.371.35-2.67-6.58118.3663.15
Financing Cash Flow
-611.16-261.21-465.82-463.85-422.44-484.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-68.0625.61-6.13-13.4428.17-32.71
Net Cash Flow
-90.88-184.26-253.72-78.43573.09-63.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
574.6338.4191.07360.85326.74409.31
Free Cash Flow Growth
451.10%-79.90%-47.05%10.44%-20.17%-39.01%
Free Cash Flow Margin
14.88%1.02%4.78%8.75%7.46%9.39%
Free Cash Flow Per Share
0.580.040.190.360.330.41
Levered Free Cash Flow
319.12168.48136.88389.58279.35310.37
Unlevered Free Cash Flow
320.01171.38138.84391.68283.28324.81
Free Cash Flow After Leases
569.5733.35186.56350.46320.66403.77

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
313.71293.96254.06286.67423.25380.93
Change in Working Capital
-465.21-465.21-286.56-233.08-232.19-138.66